Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Cost-effectiveness of hepatitis A vaccination for adults in Belgium.

Luyten J, Van de Sande S, de Schrijver K, Van Damme P, Beutels P.

Vaccine. 2012 Sep 14;30(42):6070-80. doi: 10.1016/j.vaccine.2012.07.049. Epub 2012 Aug 2.

PMID:
22858555
2.

Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States.

Rein DB, Hicks KA, Wirth KE, Billah K, Finelli L, Fiore AE, Hoerger TJ, Bell BP, Armstrong GL.

Pediatrics. 2007 Jan;119(1):e12-21.

PMID:
17200237
3.

A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China.

Zhuang GH, Pan XJ, Wang XL.

Vaccine. 2008 Aug 18;26(35):4608-16. doi: 10.1016/j.vaccine.2008.05.086. Epub 2008 Jun 13.

PMID:
18597903
4.

Regional variation in the cost effectiveness of childhood hepatitis A immunization.

Jacobs RJ, Greenberg DP, Koff RS, Saab S, Meyerhoff AS.

Pediatr Infect Dis J. 2003 Oct;22(10):904-14.

PMID:
14551492
6.

Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted.

Ellis A, Rüttimann RW, Jacobs RJ, Meyerhoff AS, Innis BL.

Rev Panam Salud Publica. 2007 Jun;21(6):345-56.

PMID:
17761046
7.

Cost-effectiveness of universal childhood hepatitis A vaccination in Chile.

Valenzuela MT, Jacobs RJ, Arteaga O, Navarrete MS, Meyerhoff AS, Innis BL.

Vaccine. 2005 Jul 14;23(32):4110-9. Epub 2005 Apr 12.

PMID:
15964479
8.

[Cost-utility analysis on universal childhood hepatitis A vaccination in regions with different anti-HAV prevalence rates of China].

Pan XJ, Feng YM, Zhuang GH.

Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Aug;33(8):862-6. Chinese.

PMID:
22967346
9.

The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States.

Arguedas MR, Heudebert GR, Fallon MB, Stinnett AA.

Am J Gastroenterol. 2002 Mar;97(3):721-8.

PMID:
11922569
10.

Cost-benefit analysis of hepatitis a vaccination in Thailand.

Teppakdee A, Tangwitoon A, Khemasuwan D, Tangdhanakanond K, Suramaethakul N, Sriratanaban J, Poovorawan Y.

Southeast Asian J Trop Med Public Health. 2002 Mar;33(1):118-27.

PMID:
12118439
11.

Cost-utility of universal hepatitis A vaccination in Canada.

Bauch CT, Anonychuk AM, Pham BZ, Gilca V, Duval B, Krahn MD.

Vaccine. 2007 Dec 12;25(51):8536-48. Epub 2007 Oct 23.

PMID:
17996339
12.

Cost-utility analysis of hepatitis A prevention among health-care workers in Israel.

Chodick G, Lerman Y, Wood F, Aloni H, Peled T, Ashkenazi S.

J Occup Environ Med. 2002 Feb;44(2):109-15.

PMID:
11851212
13.

Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context.

Sartori AM, de Soárez PC, Novaes HM, Amaku M, de Azevedo RS, Moreira RC, Pereira LM, Ximenes RA, Martelli CM.

Vaccine. 2012 Dec 14;30(52):7489-97. doi: 10.1016/j.vaccine.2012.10.056. Epub 2012 Oct 27.

14.

Cost-effectiveness of hepatitis A vaccination for individuals with chronic hepatitis C.

Chapko MK, Yee HS, Monto A, Dominitz JA.

Vaccine. 2010 Feb 17;28(7):1726-31. doi: 10.1016/j.vaccine.2009.12.019. Epub 2009 Dec 29.

PMID:
20044051
15.

Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies.

Anonychuk AM, Tricco AC, Bauch CT, Pham B, Gilca V, Duval B, John-Baptiste A, Woo G, Krahn M.

Pharmacoeconomics. 2008;26(1):17-32. Review.

PMID:
18088156
16.

The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A.

Jacobs RJ, Koff RS, Meyerhoff AS.

Am J Gastroenterol. 2002 Feb;97(2):427-34.

PMID:
11866283
17.

Universal vaccination of children against hepatitis A in Chile: a cost-effectiveness study.

Quezada A, Baron-Papillon F, Coudeville L, Maggi L.

Rev Panam Salud Publica. 2008 May;23(5):303-12.

PMID:
18510790
18.

Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates.

Jacobs RJ, Rosenthal P, Meyerhoff AS.

Vaccine. 2004 Mar 12;22(9-10):1241-8.

PMID:
15003653
19.

Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands).

Postma MJ, Bos JM, Beutels P, Schilthuis H, van den Hoek JA.

Vaccine. 2004 May 7;22(15-16):1862-7.

PMID:
15121296
Items per page

Supplemental Content

Write to the Help Desk